Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ferrexpo delays release of annual results

(Sharecast News) - Ukraine-focused iron ore pellet producer Ferrexpo has delayed the release of its annual results due to ongoing events in Ukraine as well as the legal discussions surrounding its mining unit. The Switzerland-based firm, which was due to report on Wednesday, said last week that a Ukrainian district court had granted a request from prosecutors to transfer 49.5% of its mining unit, Poltava Mining, to the state ownership in relation to an embezzlement case.

As a result, Ferrexpo said that "more time is needed" to finalise the results.

"The company will make further announcements relating to the finalisation and release of the full year financial results as appropriate," Ferrexpo said in a statement.

Ukrainian authorities have been investigating alleged embezzlement of funds from Bank Finance & Credit, a Ukrainian bank previously owned by Kostyantyn Zhevago which was declared insolvent in 2015.

Zhevago, who was arrested in absentia in July 2024, doesn't directly own shares in Poltava Mining, which is 100%-owned by Switzerland-incorporated Ferrexpo AG, which is in turn 100%-owned by Ferrexpo Plc. Zhevago owns 49.5% in Ferrexpo Plc.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.